Chemplast Sanmar

Why is Chemplast Sanmar Ltd falling/rising?

As of 12-Jun, Chemplast Sanmar Ltd's stock price is rising to Rs 202.95, reflecting a 2.89% increase today. Despite this short-term gain, the company faces significant long-term challenges, including a 22.54% year-to-date decline and high debt levels.

As of 12-Jun, Chemplast Sanmar Ltd's stock price is rising, currently at Rs 202.95, reflecting a change of Rs 5.7 or 2.89% increase. This upward movement is notable as the stock has outperformed its sector by 0.87% today and reached an intraday high of Rs 210.2, which is a 6.57% increase. Despite this positive performance today, the stock has faced significant challenges over the longer term, including a year-to-date decline of 22.54% and a staggering 53.45% drop over the past year.<BR><BR>The stock's current rise can be attributed to several positive factors, including high management efficiency indicated by a return on capital employed (ROCE) of 19.61% and substantial growth in profit before tax (PBT), which increased by 178.3% compared to the previous four-quarter average. Additionally, the company reported its highest net sales at Rs 1,255.55 crore, which may have contributed to the positive sentiment among investors today.<BR><BR>However, it is essential to note that the stock's overall performance remains under pressure due to its high debt-to-EBITDA ratio of 9.86 times, indicating a low ability to service debt. The company has also shown poor long-term growth, with net sales declining at an annual rate of 7.98% over the last five years. Furthermore, the stock has consistently underperformed against benchmarks, generating negative returns over the past year and three years.<BR><BR>In summary, while Chemplast Sanmar Ltd is experiencing a rise in stock price today, driven by strong operational metrics and outperformance relative to its sector, the broader context of its financial health and long-term performance remains concerning.

Which are the latest news on Chemplast Sanmar?

What does Chemplast Sanmar do?

Chemplast Sanmar Ltd is a small-cap company in the commodity chemicals industry, incorporated in 1985, with recent quarterly net sales of ₹1,256 Cr and a net profit of -₹45 Cr as of March 2026. The company has a market cap of ₹3,267 Cr and operates from Chennai, Tamil Nadu.

Overview: <BR>Chemplast Sanmar Ltd operates in the commodity chemicals industry and is categorized as a small-cap company.<BR><BR>History: <BR>Incorporated in 1985, Chemplast Sanmar Limited was initially promoted as 'Urethanes India' and became a fully-owned subsidiary of Chemplast in 1991. The company changed its name from Chemicals & Plastics India Limited to Chemplast Sanmar Limited on September 28, 1995. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 1,256 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: -45 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 3,267 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.76 <BR>Return on Equity: -7.41% <BR>Price to Book: 1.78<BR><BR>Contact Details: <BR>Address: 9 Cathedral Road, Chennai Tamil Nadu: 600086 <BR>Tel: +91-44-28128500 <BR>Email: grd@sanmargroup.com <BR>Website: http://www.chemplastsanmar.com

How big is Chemplast Sanmar?

As of 10th June, Chemplast Sanmar Ltd has a market capitalization of 3,267.00 Cr and reported Net Sales of 4,223.79 Cr, with a Net Profit loss of 279.87 Cr over the latest 4 quarters. Shareholder's Funds are 2,068.43 Cr and Total Assets are 6,503.19 Cr.

As of 10th June, Chemplast Sanmar Ltd has a market capitalization of 3,267.00 Cr, classifying it as a Small Cap company.<BR><BR>In the latest 4 quarters, Chemplast Sanmar reported Net Sales of 4,223.79 Cr. However, the company experienced a loss of 279.87 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. Shareholder's Funds amounted to 2,068.43 Cr, while Total Assets were reported at 6,503.19 Cr.

Who are in the management team of Chemplast Sanmar?

The management team of Chemplast Sanmar includes Vijay Sankar (Chairman), Ramkumar Shankar (Managing Director), and several independent and non-executive directors, including Lakshmi Vijayakumar, Aditya Jain, and Sanjay Bhandarkar, among others. M Raman serves as the Company Secretary & Compliance Officer.

The management team of Chemplast Sanmar includes the following individuals:<BR><BR>1. **Vijay Sankar** - Chairman (Non-Executive)<BR>2. **Ramkumar Shankar** - Managing Director<BR>3. **Chandran Ratnaswami** - Non-Executive & Non-Independent Director<BR>4. **Lakshmi Vijayakumar** - Independent Director<BR>5. **Aditya Jain** - Independent Director<BR>6. **Sanjay Bhandarkar** - Independent Director<BR>7. **Prasad R Menon** - Independent Director<BR>8. **M Raman** - Company Secretary & Compliance Officer<BR>9. **Vikram Taranath Hosangady** - Non-Executive Director<BR><BR>If you have any more questions about Chemplast Sanmar or its operations, feel free to ask!

Who are the peers of the Chemplast Sanmar?

Chemplast Sanmar's peers include Gujarat Alkalies, GHCL, Tanfac Inds., and others, with varying management risks and growth ratings. Chemplast Sanmar has the lowest 1-year return at -54.49%, significantly underperforming its peers.

Peers: The peers of Chemplast Sanmar are Gujarat Alkalies, GHCL, Tanfac Inds., Grauer & Weil, Fischer Medical, Thirumalai Chem., J.G.Chemicals, I G Petrochems, and TGV Sraac.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Tanfac Inds., while Average management risk is found at Gujarat Alkalies, Grauer & Weil, Thirumalai Chem., J.G.Chemicals, I G Petrochems, and TGV Sraac, and Below Average at Fischer Medical. Growth is rated as Excellent for Fischer Medical, Good for Tanfac Inds. and J.G.Chemicals, and Below Average for Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, Thirumalai Chem., I G Petrochems, and TGV Sraac. Capital Structure is rated as Excellent for Gujarat Alkalies, GHCL, Tanfac Inds., J.G.Chemicals, and I G Petrochems, Below Average for Chemplast Sanmar and Thirumalai Chem., and Good for Fischer Medical and TGV Sraac.<BR><BR>Return Snapshot: The peer with the highest 1-year return is J.G.Chemicals at 10.19%, while the lowest is Chemplast Sanmar at -54.49%, indicating that Chemplast Sanmar's return is significantly worse than its peers. Additionally, peers such as GHCL, Fischer Medical, Thirumalai Chem., and Chemplast Sanmar have negative six-month returns.

Should I buy, sell or hold Chemplast Sanmar Ltd?

Are Chemplast Sanmar Ltd latest results good or bad?

Chemplast Sanmar Ltd's latest results are mixed; while net sales increased by 50.34% and operating margins improved, the company reported a net loss of ₹45.38 crores for the sixteenth consecutive quarter, raising concerns about its ongoing financial distress and high debt levels.

Chemplast Sanmar Ltd's latest results present a mixed picture. In the fourth quarter of FY26, the company reported a net loss of ₹45.38 crores, which, while an improvement of 61.93% from the previous quarter's loss, still reflects ongoing financial distress as it marks the sixteenth consecutive quarter of negative earnings. <BR><BR>On the positive side, the company achieved a significant revenue increase, with net sales rising by 50.34% quarter-on-quarter to ₹1,255.55 crores, driven by better realizations and volume growth in its specialty chemicals segment. Additionally, the operating margin improved to 15.48%, the highest in eight quarters, indicating operational efficiency.<BR><BR>However, despite these operational improvements, the inability to convert revenue growth into profitability raises concerns. The company's high debt burden and persistent losses suggest structural issues that may hinder its recovery. The overall sentiment among investors appears cautious, as reflected in the stock's significant decline over the past year.<BR><BR>In summary, while Chemplast Sanmar has shown operational improvements, the continued net losses and high debt levels indicate that the results are more concerning than positive.

When is the next results date for Chemplast Sanmar Ltd?

The next results date for Chemplast Sanmar Ltd is 25 May 2026.

The next results date for Chemplast Sanmar Ltd is scheduled for 25 May 2026.

Is Chemplast Sanmar technically bullish or bearish?

As of December 2, 2025, Chemplast Sanmar's technical trend has shifted to a bearish stance with moderate strength, supported by bearish indicators across multiple timeframes, despite some mildly bullish signals in the monthly analysis.

As of 2 December 2025, the technical trend for Chemplast Sanmar has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and KST on both weekly and monthly timeframes, and bearish moving averages on the daily chart. The Dow Theory also confirms a bearish trend across both weekly and monthly perspectives. Despite a mildly bullish monthly MACD and bullish monthly RSI, the overall technical picture remains negative, particularly in the short term.

How has been the historical performance of Chemplast Sanmar?

Chemplast Sanmar's historical performance shows a decline in net sales and profits from a peak in March 2022, with net sales dropping from 5,891.99 Cr to 4,346.07 Cr by March 2025, and profit after tax turning negative at -110.36 Cr. Despite an increase in total assets and liabilities, the company has faced significant challenges in profitability and cash flow in recent years.

Answer:<BR>The historical performance of Chemplast Sanmar shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemplast Sanmar's net sales peaked at 5,891.99 Cr in March 2022 but have since declined to 4,346.07 Cr in March 2025. The total operating income followed a similar pattern, reaching a high of 5,891.99 Cr in March 2022 before dropping to 4,346.07 Cr in March 2025. The company experienced significant variations in operating profit, with a high of 1,254.29 Cr in March 2022, but a decline to 265.72 Cr by March 2025. Profit before tax turned negative in March 2024 and 2025, with figures of -225.57 Cr and -169.07 Cr, respectively, after being positive in earlier years. The profit after tax also reflected this downturn, moving from a high of 648.65 Cr in March 2022 to -110.36 Cr in March 2025. Total liabilities increased from 4,107.54 Cr in March 2020 to 6,503.19 Cr in March 2025, while total assets rose from 4,107.54 Cr to 6,503.19 Cr in the same period. Cash flow from operating activities has been negative in the last two years, with -244.00 Cr in March 2024 and a further decline in March 2025. Overall, Chemplast Sanmar's financial performance indicates challenges in profitability and cash flow, despite growth in total assets and liabilities.

Who are the top shareholders of the Chemplast Sanmar?

The top shareholders of Chemplast Sanmar are Sanmar Holdings Limited with 54.99%, mutual funds owning 24.11%, and foreign institutional investors holding 13.27%. SBI Long Term Equity Fund is the largest public shareholder at 9.82%, while individual investors hold about 4.57%.

The top shareholders of Chemplast Sanmar include Sanmar Holdings Limited, which holds the largest stake at 54.99%. Other significant shareholders are mutual funds, which collectively own 24.11% through 12 schemes, and foreign institutional investors (FIIs) with a combined holding of 13.27% across 80 FIIs. Additionally, SBI Long Term Equity Fund is the highest public shareholder with 9.82%. Individual investors hold about 4.57% of the company.

Is Chemplast Sanmar overvalued or undervalued?

As of June 12, 2025, Chemplast Sanmar is considered overvalued with a PE ratio of -62.46 and an EV to EBITDA of 36.64, underperforming the Sensex with a stock return of -17.71% compared to the Sensex's 6.64%.

As of 12 June 2025, Chemplast Sanmar's valuation grade has moved from fair to expensive. The company is currently overvalued, with a PE ratio of -62.46, an EV to EBITDA ratio of 36.64, and a Price to Book Value of 3.33. These ratios indicate significant concerns regarding profitability and valuation relative to its assets.<BR><BR>In comparison to its peers, Chemplast Sanmar's valuation stands out unfavorably; for instance, Godrej Industries is rated attractive with a PE of 44.06 and an EV to EBITDA of 33.16. Additionally, Solar Industries is categorized as very expensive with a PE of 124.55 and an EV to EBITDA of 76.70. Furthermore, Chemplast Sanmar has underperformed the Sensex over the past year, with a stock return of -17.71% compared to the Sensex's 6.64%, reinforcing the notion that the stock is currently overvalued.

Has Chemplast Sanmar declared dividend?

No Dividend History Available